Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report

Abstract Immunoglobulin light chain (AL) and wild‐type transthyretin (ATTRwt) amyloidosis, while sharing similar clinical presentations, require distinct treatments. We report a rare case of a 75‐year‐old man with heart failure diagnosed with concurrent AL and ATTRwt cardiac amyloidosis. Immunohisto...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Taiki Nishihara, Yawara Kawano, Masayoshi Tasaki, Ayuko Naito, Hiromichi Yuki, Yasuhiro Nagayoshi, Seiji Takashio, Nao Nishimura, Mitsuharu Ueda, Kenichi Tsujita, Jun‐Ichirou Yasunaga
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-08-01
Edice:	eJHaem
Témata:	AL amyloidosis ATTR amyloidosis case report daratumumab tafamidis
On-line přístup:	https://doi.org/10.1002/jha2.70122
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!